• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Tactile Systems Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/7/26 5:06:37 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care
    Get the next $TCMD alert in real time by email
    false --12-31 0001027838 TACTILE SYSTEMS TECHNOLOGY INC 0001027838 2026-05-06 2026-05-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of

    The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported):  May 6, 2026

     

    TACTILE SYSTEMS TECHNOLOGY, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-37799   41-1801204
    (State or other jurisdiction of   (Commission   (IRS Employer
    incorporation)   File Number)   Identification No.)

     

    3701 Wayzata Blvd, Suite 300, Minneapolis, MN 55416

    (Address of principal executive offices) (Zip Code)

     

    (612) 355-5100

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol(s) Name of each exchange on which
    registered
    Common Stock, Par Value $0.001 Per Share TCMD The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).  ¨ Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

      

     

     

     

    Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

     

    As further described below in Item 5.07 of this Current Report on Form 8-K, on May 6, 2026, at the Annual Meeting of Stockholders of Tactile Systems Technology, Inc. (the “Company”), the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law. On May 6, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation that sets forth the Amendment (the “Certificate of Amendment”).

     

    A description of the Amendment is set forth in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 25, 2026 (the “Proxy Statement”) in the section entitled “Proposal 4 – Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Provide that Directors May Be Removed in a Manner Consistent with Delaware Law.” The foregoing description of the Amendment is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference. A copy of the Amended and Restated Certificate of Incorporation, as amended by the Amendment, is filed as Exhibit 3.2 to this Current Report on Form 8-K and incorporated herein by reference.

     

    Item 5.07.Submission of Matters to a Vote of Security Holders

     

    On May 6, 2026, the Company held its 2026 Annual Meeting of Stockholders and the Company’s stockholders voted on the following matters:

     

    Election of Directors

     

    The following nominees were elected to serve as directors for a term that will last until the Company’s 2027 Annual Meeting of Stockholders or until his or her successor is duly elected and qualified. The number of votes cast for and withheld from each nominee and the number of broker non-votes with respect to each nominee were as follows:

     

    Name  Votes For  Votes Withheld  Broker Non-Votes
    William W. Burke  15,377,180  434,882  3,011,527
    Valerie L. Asbury  15,637,841  174,221  3,011,527
    Sheri L. Dodd  15,564,050  248,012  3,011,527
    Raymond O. Huggenberger  15,585,716  226,346  3,011,527
    Laura G. King  15,753,768  58,294  3,011,527
    Andrea A. Pearson  15,753,524  58,538  3,011,527
    D. Brent Shafer  15,706,769  105,293  3,011,527
    Carmen B. Volkart  15,749,989  62,073  3,011,527
    B. Vindell Washington  15,477,784  334,278  3,011,527

     

    Ratification of the Selection of Grant Thornton LLP as the Company’s Independent Auditor for 2026

     

    The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Grant Thornton LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 by voting as follows:

     

    For  Against  Abstain  Broker Non-Votes
    18,499,882  126,747  196,960  N/A

     

     

     

     

    Advisory Vote on Approval of the Compensation of the Company’s Named Executive Officers

     

    The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers by voting as follows:

     

    For  Against  Abstain  Broker Non-Votes
    15,375,172  376,801  60,089  3,011,527

     

    Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation

     

    The Company’s stockholders approved the proposal to amend the Company’s Amended and Restated Certificate of Incorporation to provide that directors may be removed in a manner consistent with Delaware law by voting as follows:

     

    For  Against  Abstain  Broker Non-Votes
    14,870,767  934,687  6,608  3,011,527

     

    Item 9.01.Financial Statements and Exhibits

     

    (d) Exhibits

     

    EXHIBIT INDEX

     

    Exhibit
    No.
      Description
         
    3.1   Certificate of Amendment to Amended and Restated Certificate of Incorporation, dated May 6, 2026
         
    3.2   Amended and Restated Certificate of Incorporation, conformed version reflecting all amendments through May 6, 2026
         
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      TACTILE SYSTEMS TECHNOLOGY, INC.
       
    Date: May 7, 2026 By: /s/ Elaine M. Birkemeyer
        Elaine M. Birkemeyer
        Chief Financial Officer

     

     

     

    Get the next $TCMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TCMD

    DatePrice TargetRatingAnalyst
    5/7/2026$36.00Neutral → Buy
    B. Riley Securities
    1/5/2026$35.00Neutral → Overweight
    Piper Sandler
    11/4/2025$28.00Neutral → Buy
    BTIG Research
    10/3/2025$23.50Buy
    Lake Street
    5/6/2025$14.00Overweight → Neutral
    Piper Sandler
    2/19/2025$23.00 → $18.00Buy → Neutral
    B. Riley Securities
    11/5/2024Outperform → Perform
    Oppenheimer
    11/5/2024Buy → Neutral
    BTIG Research
    More analyst ratings

    $TCMD
    SEC Filings

    View All

    SEC Form 144 filed by Tactile Systems Technology Inc.

    144 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    5/11/26 3:21:28 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Systems Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)

    5/7/26 5:06:37 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 filed by Tactile Systems Technology Inc.

    S-8 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Filer)

    5/4/26 5:26:25 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $TCMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

    MINNEAPOLIS, June 02, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced full commercial launch of its next-generation AffloVest high-frequency chest wall oscillation (HFCWO) therapy system. The next-generation system maintains its indication for use as a treatment option for chronic neuromuscular and respiratory conditions, including cystic fibrosis and bronchiectasis, across pediatric and geriatric populations, while introducing enhancements to patient comfort, ease of use, and connected care capabilities to support long-term therapy

    6/2/26 8:00:00 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

    MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL, from June 2-4, 2026. Management will present on Tuesday, June 2, at 9:20 a.m. Central Time. A live audio webcast of the presentation will be accessible under the "Events & Webcasts" section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for

    5/20/26 4:05:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

    MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 23% year-over-year to $75.3 millionGross margin of 76.5% versus 74% in Q1 2025Net loss of $1.8 million versus $3.0 million in Q1 2025Adjusted EBITDA of $3.7 million versus an Adjusted EBITDA loss of $0.3 million in Q1 2025Expanded AI-enabled order management platform with the implementation of new operational capabilities

    5/4/26 4:05:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $TCMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Birkemeyer Elaine M. sold $113,404 worth of shares (4,631 units at $24.49), decreasing direct ownership by 3% to 130,188 units (SEC Form 4)

    4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)

    5/13/26 5:01:02 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Director Asbury Valerie L. was granted 6,521 shares, increasing direct ownership by 13% to 55,343 units (SEC Form 4)

    4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)

    5/8/26 5:31:56 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Director Huggenberger Raymond was granted 6,521 shares, increasing direct ownership by 12% to 62,841 units (SEC Form 4)

    4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)

    5/8/26 5:31:28 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $TCMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tactile Systems upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded Tactile Systems from Neutral to Buy and set a new price target of $36.00

    5/7/26 7:24:33 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Systems upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Tactile Systems from Neutral to Overweight and set a new price target of $35.00

    1/5/26 8:37:29 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Systems upgraded by BTIG Research with a new price target

    BTIG Research upgraded Tactile Systems from Neutral to Buy and set a new price target of $28.00

    11/4/25 7:20:09 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $TCMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Tactile Systems Technology Inc.

    SC 13G/A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    11/13/24 7:29:11 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Tactile Systems Technology Inc.

    SC 13G - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    11/13/24 5:04:27 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Tactile Systems Technology Inc.

    SC 13G - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    11/8/24 3:21:42 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $TCMD
    Financials

    Live finance-specific insights

    View All

    Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

    MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Summary and Recent Business Highlights: Total revenue increased 23% year-over-year to $75.3 millionGross margin of 76.5% versus 74% in Q1 2025Net loss of $1.8 million versus $3.0 million in Q1 2025Adjusted EBITDA of $3.7 million versus an Adjusted EBITDA loss of $0.3 million in Q1 2025Expanded AI-enabled order management platform with the implementation of new operational capabilities

    5/4/26 4:05:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical to Release First Quarter of Fiscal Year 2026 Financial Results on May 4, 2026

    MINNEAPOLIS, April 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2026 financial results will be released after the market closes on Monday, May 4, 2026. Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on May 4, 2026, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13759535. A live webcast of the call will also be provided on the

    4/20/26 4:05:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Summary: Total revenue increased 21% year-over-year to $103.6 millionGross margin of 78% versus 75% in Q4 2024Net income of $10.6 million versus $9.7 million in Q4 2024Adjusted EBITDA of $22.9 million versus $16.2 million in Q4 2024 Full Year 2025 Summary: Total revenue increased 12% year-over-year to $329.5 millionGross margin of 76%, compared to 74% in 2024Oper

    2/17/26 4:05:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $TCMD
    Leadership Updates

    Live Leadership Updates

    View All

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson

    MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company's Board of Directors ("Board") and as a member of the Compliance & Reimbursement and Nominating & Corporate Governance Committees, effective March 9, 2026. Ms. Pearson is an accomplished senior executive and growth strategist with deep expertise in scaling healthcare organizations. Her extensive experience spans more than 25 years and includes exposure to product development, customer acquisition, branding, market

    3/9/26 8:00:00 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical Appoints Laura King to Board of Directors

    MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company's Board of Directors ("Board") and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient care. Her extensive experience includes a 22-year career at General Electric Company (GE), where she served as a Company Officer in her role as President & CEO of GE

    1/13/25 8:00:00 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care